138 related articles for article (PubMed ID: 573509)
21. Structure and pathogenesis of plexiform lesion in pulmonary hypertension.
Ogata T; Iijima T
Chin Med J (Engl); 1993 Jan; 106(1):45-8. PubMed ID: 8504682
[TBL] [Abstract][Full Text] [Related]
22. The histopathology of 36 cases of plexogenic pulmonary arteriopathy.
Caslin AW; Heath D; Madden B; Yacoub M; Gosney JR; Smith P
Histopathology; 1990 Jan; 16(1):9-19. PubMed ID: 2307421
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary endocrine cells in pulmonary arterial disease.
Gosney J; Heath D; Smith P; Harris P; Yacoub M
Arch Pathol Lab Med; 1989 Apr; 113(4):337-41. PubMed ID: 2705865
[TBL] [Abstract][Full Text] [Related]
24. Comparison of primary plexogenic arteriopathy in adults and children. A morphometric study in 40 patients.
Yamaki S; Wagenvoort CA
Br Heart J; 1985 Oct; 54(4):428-34. PubMed ID: 4052282
[TBL] [Abstract][Full Text] [Related]
25. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy.
Greenway S; van Suylen RJ; Du Marchie Sarvaas G; Kwan E; Ambartsumian N; Lukanidin E; Rabinovitch M
Am J Pathol; 2004 Jan; 164(1):253-62. PubMed ID: 14695338
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.
Patel M; Predescu D; Bardita C; Chen J; Jeganathan N; Pritchard M; DiBartolo S; Machado R; Predescu S
Am J Pathol; 2017 Mar; 187(3):528-542. PubMed ID: 28068512
[TBL] [Abstract][Full Text] [Related]
27. Severe pulmonary arterial hypertension due to toxic oil syndrome: a new cause of plexogenic arteriopathy.
Mestre de Juan MJ; Martinez Tello FJ; Gomez Pajuelo C; Saenz de la Calzada C; Moya Mur JL; Tascon Perez JC; Lombera Romero F; Gomez Sanchez MA
Cor Vasa; 1990; 32(3):218-24. PubMed ID: 2209024
[TBL] [Abstract][Full Text] [Related]
28. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study.
Yi ES; Kim H; Ahn H; Strother J; Morris T; Masliah E; Hansen LA; Park K; Friedman PJ
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1577-86. PubMed ID: 11029379
[TBL] [Abstract][Full Text] [Related]
29. [Study on the morphometric and hemodynamic changes of the pulmonary arteries in pulmonary hypertension autopsies].
Ruan Y; Si W; Zhang L
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):89-92. PubMed ID: 9206212
[TBL] [Abstract][Full Text] [Related]
30. Pathology and aspects of pathogenesis in pulmonary arterial hypertension.
Dorfmüller P; Humbert M; Capron F; Müller KM
Sarcoidosis Vasc Diffuse Lung Dis; 2003 Mar; 20(1):9-19. PubMed ID: 12737275
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary endocrine cells in hypertensive pulmonary vascular disease.
Heath D; Yacoub M; Gosney JR; Madden B; Caslin AW; Smith P
Histopathology; 1990 Jan; 16(1):21-8. PubMed ID: 2307413
[TBL] [Abstract][Full Text] [Related]
32. The ultrastructure of pulmonary arteries and arterioles in emphysema.
Smith P; Rodgers B; Heath D; Yacoub M
J Pathol; 1992 May; 167(1):69-75. PubMed ID: 1625061
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary vascular lesions in the toxic oil syndrome in Spain.
Fernández-Segoviano P; Esteban A; Martínez-Cabruja R
Thorax; 1983 Oct; 38(10):724-9. PubMed ID: 6648850
[TBL] [Abstract][Full Text] [Related]
34. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.
Giaid A; Yanagisawa M; Langleben D; Michel RP; Levy R; Shennib H; Kimura S; Masaki T; Duguid WP; Stewart DJ
N Engl J Med; 1993 Jun; 328(24):1732-9. PubMed ID: 8497283
[TBL] [Abstract][Full Text] [Related]
35. CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension.
Ohta-Ogo K; Hao H; Ishibashi-Ueda H; Hirota S; Nakamura K; Ohe T; Ito H
Pathol Int; 2012 Apr; 62(4):219-25. PubMed ID: 22449225
[TBL] [Abstract][Full Text] [Related]
36. Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease.
Geiger R; Berger RM; Hess J; Bogers AJ; Sharma HS; Mooi WJ
J Pathol; 2000 Jun; 191(2):202-7. PubMed ID: 10861582
[TBL] [Abstract][Full Text] [Related]
37. Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats.
Otsuki S; Sawada H; Yodoya N; Shinohara T; Kato T; Ohashi H; Zhang E; Imanaka-Yoshida K; Shimpo H; Maruyama K; Komada Y; Mitani Y
PLoS One; 2015; 10(2):e0118655. PubMed ID: 25714834
[TBL] [Abstract][Full Text] [Related]
38. Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression.
Bockmeyer CL; Maegel L; Janciauskiene S; Rische J; Lehmann U; Maus UA; Nickel N; Haverich A; Hoeper MM; Golpon HA; Kreipe H; Laenger F; Jonigk D
J Heart Lung Transplant; 2012 Jul; 31(7):764-72. PubMed ID: 22534459
[TBL] [Abstract][Full Text] [Related]
39. Immunocytochemical detection of progesterone receptors. A study in a patient with primary pulmonary hypertension.
Barberis MC; Veronese S; Bauer D; De Juli E; Harari S
Chest; 1995 Mar; 107(3):869-72. PubMed ID: 7874968
[TBL] [Abstract][Full Text] [Related]
40. Intravascular papillary endothelial hyperplasia: light and electron microscopic observations of a case.
Kreutner A; Smith RM; Trefny FA
Cancer; 1978 Nov; 42(5):2304-10. PubMed ID: 569010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
